Company / Revenue per Share
Rani Therapeutics Holdings, Inc. Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$36.10
FY2025
5-year range
$0.00 / $139.09
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $139.09 to $36.10 over the past 3 years.
Based on SEC 10-K filings.
36.10 in FY2025 with a 3-year CAGR of -36.2%.
Declined from $139.09 to $36.10 over the past 3 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -36.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.10 | - |
| FY2024 | $0.00 | -100.0% |
| FY2022 | $139.09 | +587995.2% |
| FY2021 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026